Signaling pathways
-
BA6659 BasmisanilSummary: Basmisanil (RG1662) is a highly selective alpha-subunit-containing GABAA receptor (GABAAα5)-negative modulator with oral activity. -
BA6660 AZD7325Summary: A potent and orally active selective positive allosteric modulator of GABAA α2 and α3 receptors -
BA6661 EtifoxineSummary: Etifoxine is a non-benzodiazepine, GABAergic compound that is a positive modifier of the receptor subunits α1β2γ2 and α1β3γ2.
-
BA6662 AfloqualoneSummary: Afloqualone (HQ-495) is a GABAergic reagent with agonist activity on the β-subtype of the -
BA6666 MRK-016Summary: MRK-016 is a selective, orally available, antagonist that crosses the blood-brain barrier.
-
BA6667 KavainSummary: Kavain is a class of kavalactones with anxiolytic effects in animals and humans.
-
BA6669 BPDBASummary: BPDBA is a selective and noncompetitive inhibitor of the betaine/GABA transporter.
-
BA6670 CirsimaritinSummary: Cirsimaritin weakly targets the benzodiazepine site on the binding receptor.
-
BA6671 ArecaidineSummary: Arecaidine, a pyridine alkaloid, is a potent absorption inhibitor.
-
BA6672 ONO-8590580Summary: Negative deformation modifiers.